The adult epilepsy market is expected to grow from $5.82 billion in 2020 to $8.35 billion by 2030 across the seven major markets (7MM*) at a compound annual growth rate (CAGR) of 3.7 per cent, according to GlobalData.
Among infants breastfed by mothers who are receiving drug therapy for epilepsy, antiepileptic drug (AED) concentrations in infant blood samples are substantially lower than those in ...
Optimized placement of automated external defibrillators (AEDs) could increase out-of-hospital cardiac arrest (OHCA) coverage over real AED placements...
It is available in tablet form to be taken once daily, and a new oral suspension formulation has been approved and is being marketed in the United States